U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07781852) titled 'Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer' on Aug. 19.
Brief Summary: The objective of this study is to assess two novel positron emission tomography (PET) radiotracers, [64Cu]CM500 and [68Ga]CM500, for PET-MR and PET-CT imaging of solid tumors. These tracers have the potential to detect solid tumors throughout the body and may enable doctors to identify smaller tumors than conventional imaging techniques.
Study Start Date: Sept. 01
Study Type: INTERVENTIONAL
Condition:
Bladder Cancer
Glioma
Glioblastoma (GBM)
Breast Cancer
Colorectal Cancer
Esophageal Cancer
Gastric...